LPL Financial LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,659,715
-2.3%
107,286
-0.8%
0.00%0.0%
Q2 2023$1,699,138
-1.8%
108,156
+3.0%
0.00%0.0%
Q1 2023$1,730,448
+62.8%
105,003
+54.1%
0.00%0.0%
Q4 2022$1,063,185
+494.0%
68,153
+395.0%
0.00%
Q3 2022$179,000
-3.8%
13,769
+4.1%
0.00%
Q2 2022$186,000
-5.6%
13,228
-3.9%
0.00%
Q1 2022$197,000
-34.6%
13,759
-37.7%
0.00%
Q4 2021$301,000
-49.9%
22,075
-39.8%
0.00%
-100.0%
Q3 2021$601,000
+1.0%
36,661
+3.6%
0.00%0.0%
Q2 2021$595,000
+1.5%
35,371
+10.3%
0.00%0.0%
Q1 2021$586,000
+14.5%
32,070
+13.9%
0.00%0.0%
Q4 2020$512,000
-4.7%
28,144
-6.5%
0.00%0.0%
Q3 2020$537,000
-10.8%
30,114
-10.3%
0.00%0.0%
Q2 2020$602,000
+16.2%
33,576
-1.6%
0.00%0.0%
Q1 2020$518,000
+63.9%
34,112
+112.9%
0.00%0.0%
Q4 2019$316,000
+60.4%
16,023
+39.6%
0.00%
Q3 2019$197,000
+10.1%
11,479
+13.3%
0.00%
Q2 2019$179,000
-73.2%
10,135
-69.1%
0.00%
-100.0%
Q1 2019$668,00032,7990.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders